petra Molan
Consultant / Advisor chez Tau Ventures LLC
Profil
petra Molan currently works at Tau Ventures LLC, as Advisor.
Ms. Molan also formerly worked at Bayer AG, as Director from 2004 to 2007, Horizon Therapeutics Plc, as Board Director from 2021 to 2022, Shire Biologics, Inc., as Senior Vice president in 2018, Takeda AB, as Senior Vice president, and Arvelle Therapeutics BV, as Chief Commercial Officer from 2019 to 2021.
Ms. Molan received her graduate degree in 2003 from the University of Ljubljana.
Postes actifs de petra Molan
| Sociétés | Poste | Début |
|---|---|---|
Tau Ventures LLC
 Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Consultant / Advisor | - |
Anciens postes connus de petra Molan
| Sociétés | Poste | Fin |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Director/Board Member | 02/12/2022 |
Arvelle Therapeutics BV
 Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Corporate Officer/Principal | 02/06/2021 |
| Takeda AB | Private Equity Investor | 02/11/2019 |
Shire Biologics, Inc.
 Shire Biologics, Inc. Pharmaceuticals: MajorHealth Technology Shire Biologics, Inc. is an American company that manufactures pharmaceutical medicines. | Private Equity Investor | 02/12/2018 |
| BAYER AG | Private Equity Investor | 02/08/2007 |
Formation de petra Molan
| University of Ljubljana | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BAYER AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Biologics, Inc.
Shire Biologics, Inc. Pharmaceuticals: MajorHealth Technology Shire Biologics, Inc. is an American company that manufactures pharmaceutical medicines. | Health Technology |
| Takeda AB | |
Arvelle Therapeutics BV
Arvelle Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Arvelle Therapeutics BV is a Dutch biopharmaceutical company that focuses on providing innovative solutions to patients with CNS disorders. The private company is responsible for developing and commercializing an investigational anti-seizure medicine called Cenobamate in the European market. Arvelle received start-up financing of $207.80 million, which is one of the largest initial financing commitments for a European-focused biopharmaceutical company. The company is headquartered in Amsterdam, Netherlands. Arvelle was founded by Gregory Mark Weinhoff and Mark F. Altmeyer, and Mark F. Altmeyer has been the CEO since incorporation. | Commercial Services |
Tau Ventures LLC
Tau Ventures LLC Investment ManagersFinance Tau Ventures LLC (Tau Ventures) is a venture capital firm founded in 2018 by Amit Garg and Sanjay K. Rao. The firm is headquartered in Palo Alto, California. | Finance |
